NEXN · Nexxen International Ltd. · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-04 | Niri Sagi |
Chief Financial Officer |
Award↑
|
Common Stock
|
22,822 |
| 2026-08-17 | Kerstein Daniel Yosef |
Director |
Sell↓
|
Common Stock
|
11,000 |
| 2026-07-28 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
17,578 |
| 2026-07-16 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
35,000 |
| 2026-07-15 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
14,668 |
| 2026-07-15 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
2,411 |
| 2026-07-15 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
17,421 |
| 2026-07-13 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
71,845 |
| 2026-07-10 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
3,655 |
| 2026-07-06 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
199 |
| 2026-07-02 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
16,609 |
| 2026-07-02 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
33,217 |
| 2026-07-01 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. Such sales were inadvertently omitted from the original Form 4 filed by the reporting person on July 01, 2026. |
Common Stock
|
6,584 |
| 2026-07-01 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. Such sales were inadvertently omitted from the original Form 4 filed by the reporting person on July 01, 2026. |
Common Stock
|
23,391 |
| 2026-07-01 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. Such sales were inadvertently omitted from the original Form 4 filed by the reporting person on July 01, 2026. |
Common Stock
|
12,717 |
| 2026-06-17 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
2,098 |
| 2026-06-16 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
2,214 |
| 2026-06-16 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
2,017 |
| 2026-06-16 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
30,436 |
| 2026-06-15 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
1,160 |
| 2026-06-12 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
200 |
| 2026-06-10 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
5,922 |
| 2026-06-04 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
13,164 |
| 2026-06-03 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. On the Original Form 4, the reporting person inadvertently reported a sale of 1,027 shares of Common Stock. In fact, as reported on this amendment, the reporting person sold 1,100 shares of Common Stock. As a result of this error, the number of shares reported as beneficially owned by the reporting person following the corrected transaction reflects a decrease in the number of shares previously reported as beneficially owned in the Original Form 4. |
Common Stock
|
1,100 |
| 2026-06-01 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
33,393 |
| 2026-06-01 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. |
Common Stock
|
364 |
| 2026-05-29 | Niri Sagi |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
1,486 |
| 2026-04-01 | Niri Sagi |
Chief Financial Officer |
Award↑
|
Common Stock
|
100,865 |